THE AZELAPRAG CLINICAL TRIALS DIARIES

In December, BioAge introduced a multi-year research collaboration with Novartis to identify and validate novel therapeutic targets in the intersection of growing old biology and work out, combining BioAge's longitudinal human growing old datasets with Novartis skills in workout biology.If this doesn’t occur for the drug plus some list of sicknes